Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis (Q33258364)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis |
scientific article |
Statements
1 reference
Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis (English)
1 reference
Matsuzaki S
1 reference
Canis M
1 reference
Pouly JL
1 reference
Botchorishvili R
1 reference
Déchelotte PJ
1 reference
Mage G
1 reference
25 September 2006
1 reference
1 reference
22
1 reference
124-128
1 reference
Identifiers
1 reference
1 reference